Reports and Briefs on Pharmaceuticals and Healthcare in India

Published within

« | 1 | 2 | 3 | 4 | » »|

Type Product title / description Pub Price
Report
Report

2009 Pharmaceutical M&A Overview

An overview of M&A trends for the top 150 global pharmaceutical companies during 2008 and 2009 with discussion of the drivers of recent deals, plus case study analysis of key M&As.

Published By Datamonitor
17 Dec 2009 $11400
Buy
Report
Report

Autoimmune Market Access in India – Market opportunities for cost-effective biosimilars

The launch and uptake of biologics has grown across India – primarily in urban areas – but affordability is a major limiting factor, thereby providing an opportunity for the pharmaceutical companies manufacturing cost-effective biosimilars.

Published By Datamonitor
25 Aug 2011 $2800
Buy
Report
Report

Biosimilars: India Update

Biosimilars: India Update provides analysis on the Indian copy biologics market. It includes an overview of drivers and resistors to biologic uptake, market access strategies, key domestic biologic players and future development trends.

Published By Datamonitor
14 Oct 2011 $1520
Buy
Report
Report

Biosimilars: Regulatory Update

Datamonitor’s report Biosimilars: Regulatory Update provides analysis on key developments in biosimilar regulations globally. It includes an overview of the background behind these events and popular strategic responses.

Published By Datamonitor
08 Dec 2011 $1520
Buy
Report
Report

BRIC: Pricing, Reimbursement, and Regulatory Update

Datamonitor’s report BRIC: Pricing, Reimbursement, and Regulatory Update provides an update of changes to pricing, reimbursement and regulation in Brazil, Russia, India and China during the first half of 2011.

Published By Datamonitor
08 Sep 2011 $1520
Buy
Report
Report

CNS Market Access in India: Government investment into CNS services set to stimulate market growth

This report examines the CNS market in India. It reviews the epidemiology and treatment of key conditions. It also provides analysis of the strengths, weaknesses, opportunities and threats of the market and strategies for market penetration.

Published By Datamonitor
28 Jun 2011 $2800
Buy
Report
Report

Commercial Insight: Antidiabetics in India - Growth in the Indian diabetes market will be driven by an increase in diagnosis and the uptake of novel drugs

Discussion of the Indian diabetes market including epidemiology, market drivers, and strategic analysis of key players. Assessment of marketed and pipeline products. Commercial forecast of market size and product sales and volumes to 2019.

Published By Datamonitor
21 Mar 2011 $2800
Buy
Report
Report

Commercial Insight: Osteoporosis - Market players maximize revenue growth before the next challenging phase

Comprehensive analysis of the current and future osteoporosis drug market, with country-specific forecasts to 2019 of marketed, generic, and key pipeline drugs in the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK).

Published By Datamonitor
21 Jul 2010 $15200
Buy
Report
Report

Epidemiology: COPD in India - Aging, population growth, and increased survival will drive a marked increase in prevalent cases of COPD over the next ten years

Overview of COPD definition and a review of the epidemiology literature for India. This report provides in-depth analysis of patient populations, a 10-year prevalent forecast, and key patient segments in India.

Published By Datamonitor
01 Apr 2011 $2800
Buy
Report
Report

Epidemiology: Diabetes in India - a country faced with a mammoth diabetes epidemic

Diabetes mellitus is becoming an important chronic disease in countries experiencing rapid economic growth, especially India. In 2010, Datamonitor estimates that there were nearly 50 million people with diabetes mellitus.

Published By Datamonitor
16 Mar 2011 $2800
Buy

« | 1 | 2 | 3 | 4 | » »|

No help is available.